Several studies assessing the inhibition of Ang-II signaling in pulmonary injury, acute respiratory distress syndrome (ARDS), pulmonary fibrosis and lung damage, confirmed the benefits of ACEi or ARBs treatment by softening cell apoptosis, fibrosis and inflammatory cytokines (CKs) release [39,40,41]. Here, AGT is linked to acute respiratory distress syndrome.